Trial
NCT06087731
Efficacy and Safety of Tocilizumab for TAO
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Tocilizumab
Intervention
Tocilizumab
Why stopped
For some personal reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-28